A Study of Pembrolizumab in Pediatric Participants With an Advanced Solid Tumor or Lymphoma
This is a two-part study of pembrolizumab (MK-3475) in pediatric participants who have any of the following types of cancer: advanced melanoma (6 months to
Clinical Trials
This is a two-part study of pembrolizumab (MK-3475) in pediatric participants who have any of the following types of cancer: advanced melanoma (6 months to